Activation of the CD95/CD95L system in cancer may result in drastically different biological outcomes, such as apoptosis, sustained cell growth, and enhanced cell invasiveness, which depend on the involved signaling pathways, interacting cell types, and tumor microenvironment [10,11]. The gene discussed is FAS; the disease is neoplasm.